PDS Biotechnology Corp 8-K

What Happened
PDS Biotechnology Corp (PDSB) announced on April 24, 2026 that it updated its corporate presentation deck. The presentation, dated April 2026, is filed as Exhibit 99.1 to the Form 8-K and is incorporated by reference into the filing.

Key Details

• Filing date: April 24, 2026; Item reported: 8.01 (Other Events).
• Exhibit filed: 99.1 — Corporate Presentation (April 2026).
• The Form 8-K also includes the Cover Page Interactive Data File (Exhibit 104).
• The filing does not contain earnings, revenue, quarterly results, CEO/CFO changes, or merger/acquisition announcements.

Why It Matters
An updated corporate presentation can provide investors with the company’s latest overview of its business, clinical pipeline, strategy, and recent developments. However, this 8-K is informational only and does not present new financial results, executive changes, or transaction details. Retail investors who want the specifics should review Exhibit 99.1 on the SEC EDGAR site or the company’s investor relations page for the updated slides.